Infinity Pharmaceuticals, Inc. (INFI): $2.98

-0.10 (-3.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add INFI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 494

in industry

Infinity Pharmaceuticals Inc (INFI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering INFI.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $12 $4 $8.5 $3.12 172.44%

The Trend in the Analyst Price Target


INFI's average price target has moved up $4.37 over the prior 112 days.

INFI reports an average of 100.96% for its upside potential over the past 330 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-05-15 4 3.5 1 2.50 0.990 152.53%
2020-07-25 4 3.5 1 2.50 0.830 201.2%
2020-07-29 4 3.5 1 2.50 0.825 203.03%
2020-11-12 4 3.5 1 2.62 1.530 71.24%
2020-12-07 4 3.5 1 2.63 2.140 22.9%
2020-12-09 4 3.5 1 2.63 2.240 17.41%
2020-12-19 4 7.0 2 4.13 2.050 101.46%
2020-12-26 4 7.0 2 4.13 2.100 96.67%
2021-01-02 4 7.0 2 4.13 2.120 94.81%
2021-01-09 4 7.0 2 4.13 2.450 68.57%
2021-01-16 4 7.0 2 4.13 3.180 29.87%
2021-01-23 4 7.0 2 4.13 4.090 0.98%
2021-01-30 4 7.0 2 4.13 3.470 19.02%
2021-02-06 4 7.0 2 4.75 3.930 20.87%
2021-02-13 4 12.0 2 7.75 4.040 91.83%
2021-02-20 5 12.0 2 7.60 3.770 101.59%
2021-02-27 5 12.0 2 7.60 3.040 150%
2021-03-06 5 12.0 2 7.60 2.690 182.53%
2021-03-13 5 12.0 2 7.60 3.120 143.59%
2021-03-20 6 12.0 4 8.67 3.640 138.19%
2021-04-03 6 12.0 4 8.50 3.320 156.02%
2021-04-10 6 12.0 4 8.50 3.310 156.8%

INFI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.57 1 4 2 0 0 7

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The variance in analysts' estimates of INFI is lower than 6.04000000000001% of all US stocks.
  • Infinity Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 91.86% of all US stocks.
  • INFI has a greater average analyst price target than 8.43% of stocks in the mid market cap category.
  • The number of analysts covering the stock of INFI is greater than 39.08% of stocks in the mid market cap category.

In the Pharmaceutical Products industry, KLDO, GRAY and NERV are the three stocks most similar to Infinity Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for INFI? Use POWR Ratings for clearer insight into price direction.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.804 seconds.